' Pituitary adenomas are uncommon in childhood. Between 1975 and 1988, 36 patients underwent transsphenoidal resection at the Mayo Clinic before their 17th birthday. Fifteen (41.7%) had prolactin (PRL)-secreting tumors, ] 6 (44.4%) had adrenocorticotropic hormone (ACTH)-secreting tumors (including two patients with Nelson-Salassa syndrome), and three (8.3%) had tumors secreting growth hormone (GH); two patients (5.6%) had clinically nonfunctioning tumors. Of the 36 patients, 21 (58.3%) were girls, and girls predominated in every group except that with ACTH-secreting tumors, where they accounted for only 37.5% of the patients. The average age at the time of surgery was 14.7 _+ 2.2 years, the youngest patient being 7.3 years old. The ACTH-secreting tumors were associated with an earlier onset of symptoms than the other tumor types: six (37.5%) of 16 patients became symptomatic before 10 years of age, compared with two (10.0%) of the 20 other patients. Presenting symptoms primarily reflected endocrine dysfunction, with neurological presentation (visual field deficits) occurring in only two patients.
p
ITUITARY adenomas account for less than 2% of all intracranial tumors in the pediatric age group. ",~4 Although several series of these rare tumors have previously been reported, some reports included patients treated in the pre-computerized tomography (CT) era, as well as patients operated on via a variety of surgical approaches, m3,2~,25,34,37,42 The purpose of this study was to review the clinical characteristics, surgical management, and long-term outcome of a series of children and adolescents with histologically verified pituitary adenomas who were operated on exclusively via the transsphenoidal approach and whose tumors were characterized by CT or magnetic resonance (MR) imaging.
Clinical Material and Methods
Charts were reviewed of all Mayo Clinic patients treated during the years 1975 through 1988 who had undergone their first transsphenoidal exploration before their 17th birthday. Patients were included in the series if they had histological confirmation of a pituitary adenoma; two patients whose exploration was negative were excluded. * Mean values are expressed _+ standard deviation.
All surgical specimens except one (which was represented only on frozen section) were formalin-fixed, paraffin-embedded, and processed routinely for light microscopy. Histochemical stains applied included hematoxylin and eosin, Gomori's reticulin, and periodic acid-Schiff. Sections 5 /xm in size were also stained immunochemically with polyclonal antisera directed toward: prolactin (PRL), dilution 1:1200; growth hormone (GH), dilution 1:800; adrenocorticotropic hormone (ACTH), dilution 1:1600;/3-follicle-stimulating hormone (FSH), dilution 1:400;/3-1uteinizing hormone (LH), dilution 1:1200; and B-thyroid-stimulating hormone (TSH), dilution 1:400. All antisera were obtained as donations from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
Further review of medical records confirmed that no transcranial operations were performed on pediatric patients with pituitary adenomas during this time period. Follow-up review was attempted in all czses, either in person at the Mayo Clinic or by letter, and was available in all cases with one exception.
Patient Characteristics
Of the 1776 patients undergoing transsphenoidal surgery for pituitary adenoma during the study period, 36 (2.03%) were children and adolescents who met the criteria for inclusion. For ease of analysis, patients were grouped according to their preoperative clinical or biochemical diagnosis: prolactinoma (PRL-secreting), Cushing's disease/Nelson-Salassa syndrome (ACTH-secreting), gigantism/acromegaly (GH-secreting), or clinically nonfunctioning adenoma. These groups are summarized in Table 1 , along with patient age and sex. There were no patients with TSH-or LH/ FSH-secreting tumors, nor was there any evidence of multiple endocrine neoplasia (type 1) syndromes. In one patient with an ACTH-secreting tumor, an aunt had previously undergone resection of a prolactinoma at our institution. The majority of patients had functioning adenomas, with approximately equal distribution between PRL-and ACTH-secreting tumors. Overall, girls predominated slightly, with the expected preponderance of girls among patients with prolactinomas outweighing the preponderance of boys with ACTHsecreting tumors. In all groups, the median age at surgery was after the 14th birthday, with the median age at onset of symptoms also occurring after the 14th birthday in all diagnostic groups except the ACTHsecreting tumors. In some patients in this group, the insidious onset of Cushing's disease symptoms was reported as early as infancy.
The group of patients with Cushing's disease included two patients with Nelson-Salassa syndrome. One of these was a girl with the onset of symptomatic Cushing's disease at I1 years of age. At the time that she was diagnosed at this institution, it was recommended that she undergo bilateral adrenalectomy and pituitary irradiation. Adrenalectomy was performed elsewhere; however, she did not receive radiotherapy. She eventually developed typical signs of NelsonSalassa syndrome and underwent transsphenoidal surgery at the Mayo Clinic 3 89 years later. The other patient was a Native American boy from northern Canada who was diagnosed with Cushing's syndrome at the age of 8 months. Neuroimaging studies were normal, and a CT scan of the abdomen was thought to demonstrate an adrenal mass. He underwent laparotomy and bilateral adrenalectomy elsewhere; however, pathological examination revealed only benign adrenal hyperplasia. The child did not return for follow-up evaluation until the age of 7 years, when a pituitary adenoma was diagnosed. He was referred to us for transsphenoidal surgery, and a microadenoma was removed without incident. The child did not return following surgery and is the only patient in this series for whom no follow-up data are available.
Clinical Presentation
The presenting symptoms of the patients are summarized in Table 2 , grouped by preoperative diagnosis. Generally, patients presented with symptomatic endocrinopathy due to hormonal hypersecretion and/or delay of linear growth or puberty. Symptoms referrable to tumor mass effect, such as headaches or visual field defects, were uncommon in functioning adenomas.
Pertinent physical examination findings are summarized in Table 3 . As was the case with the presenting symptomatology, physical signs in most cases reflected the hypersecretion syndrome, with a paucity of neurological findings. The only neurological findings were visual field defects in the patients with nonfunctioning tumors and in a minority of patients harboring PRLand GH-secreting tumors with suprasellar extension. 
Results

Laboratory and Radiological Data
In the 15 patients with PRL hypersecretion, the preoperative diagnosis was made on the basis of the serum PRL level. The mean value was 492 ng/ml (range 48 to 2916 ng/ml, normal range 0 to 20 ng/ml). Skull films were abnormal in 10 (77%) of 13 patients and angiography was diagnostic in all six patients studied. An intrasellar lesion was demonstrated by CT or MR imaging in 12 (86%) of 14 cases studied, with suprasellar extension in six patients (43%) and parasellar extension in five (36%).
Cushing's disease or Nelson-Salassa syndrome were diagnosed in 16 patients by a variety of tests, including elevated serum ACTH, elevated serum cortisol with loss of diurnal variation, and increased urinary free cortisol levels. The dexamethasone-suppression test (suppression of serum cortisol and urinary 17-hydroxycorticosteroids in response to high-dose, but not lowdose, dexamethasone) was also obtained in most cases. Petrosal sinus sampling was not being performed at the Mayo Clinic during the study period. Imaging studies were frequently normal in patients with ACTHsecreting tumors. Skull films were abnormal in only six (38%) of 16 patients, and in only one of four cases were angiograms diagnostic. Computerized tomography and/or MR imaging demonstrated an intrasellar lesion in five (42%) of 12 patients; in no case was extension present outside the sella turcica.
The three patients with GH-secreting tumors had a mean serum GH level of 153 ng/ml (range 34 to 256 ng/ml, normal ranges 0 to 5 ng/ml (male) and 0 to 10 ng/ml (female)). The findings were abnormal on skull radiography in two (67%) of three patients, on angiography in two, and on CT in two (with suprasellar extension present in both).
As expected, neither of the two patients with clinically nonfunctioning adenomas has evidence of hormonal hypersecretion, but in both there was documentation of chiasmal visual field defects. One patient had abnormal skull films and elevation of the At segments on angiograpby, while the other had a CT scan in which an intrasellar mass with suprasellar extension was demonstrated.
Surgical Techniques and Complications
All patients were operated on via the sublabial/ transseptal approach, as described elsewhere? 3.48 The initial exposure was performed in each case by an otolaryngologist. In two patients with ACTH-secreting tumors, the sphenoid sinus was not fully pneumatized (so-called "conchal" type 31) and the sellar floor was exposed by the use of a high-speed drill under fluoroscopic control. An attempt was made to preserve normal-appearing gland in each case. Frozen section was used to confirm the presence of adenomatous tissue. The sellar floor was reconstructed using a small piece of nasal bone, and the sphenoid sinus was packed with subcutaneous fat from the abdomen in cases where * PRL = prolactin; GH = growth hormone; TSH = thyroidstimulating hormone; ACTH = adrenocorticotropic hormone; LH = luteinizing hormone; FSH = follicle-stimulating hormone.
intraoperative evidence of a cerebrospinal fluid (CSF) leak was present or if a future craniotomy was anticipated.
The extent of resection was graded by the operating surgeon. In four of the 15 patients with PRL-secreting tumors, a subtotal resection was reported; in all other cases it was determined that a gross total resection was obtained.
There were no deaths in this series. Morbidity was rare; there were no CSF leaks or infections and no patient developed rhinological complications. Of three patients with diabetes insipidus postoperatively, two had complete resolution. One patient was transferred to a psychiatric ward for management of steroidinduced psychosis; she was able to be discharged from the hospital after 2 weeks and has had no further psychotic symptoms.
Pathological Data
One patient with PRL hypersecretion had a tumor identified on frozen section only; in all other cases the diagnosis of pituitary adenoma was confirmed by permanent section studies. In addition, all tumors were studied with immunohistochemistry techniques to establish their hormonal phenotypes. The results of these tests are summarized in Table 4 . Plurihormonal tumors, broadly defined as tumors producing more than one hormone, were commonly identified, being found in five (36%) of 14 PRL-secreting cases, all three GHsecreting tumors, and one of two clinically nonfunctioning adenomas. The overall incidence of plurihormonal tumors was nine (25.7%) of 35 cases. On review of the imaging studies, it was found that eight (89%) of the nine plurihormonal tumors were macroadenomas (the tumor extended beyond the confines of the M. D. Partington, et al. sella turcica). No patient had clinical or biochemical manifestation of hypersecretion of more than one hormone, although one patient with a PRL-secreting tumor, who was greater than two standard deviations above the mean height for his age, had a tumor that stained for both PRL and GH, despite normal serum GH levels.
Outcome
In all patients the visual field examination obtained prior to discharge and at follow-up review was normal, as was the neurological examination. Anterior pituitary function was preserved in the majority of cases; of 35 patients available for follow-up examination, 22 (62.9%) had full pituitary function and were not taking replacement hormones, 10 (28.6%) required partial pituitary replacement (prednisone and/or thyroxine), and three (8.6%) required full pituitary replacement. Normal menstrual cycles resumed in 18 (85.7%) of the 21 female patients; six patients who attempted to become pregnant postoperatively were successful.
Tumor status at follow-up review was also analyzed by diagnostic group. The 15 patients with PRLsecreting tumors were followed for a median period of 79 months (range 8 to 138 months). Of these, five (including the four with known subtotal resection) received adjuvant radiotherapy postoperatively and three were also treated with bromocriptine. No patient with a microadenoma required adjuvant therapy. At follow-up examination, all patients had normal serum PRL values and none had radiographic evidence of disease.
The median period of follow-up review in the 15 patients with ACTH hypersecretion was 54 months (range 4 to 163 months). An initial remission (as determined by postoperative serum cortisol levels) was achieved in 12 (80%). The three remaining patients with persisting biochemical evidence of Cushing's disease were treated with pituitary irradiation; one patient also underwent reoperation. All three patients had normal serum cortisol levels after radiotherapy and/or reoperation, and remained disease-free at follow-up review (median follow-up period 42 months, range 22 to 66 months). In the group of 12 patients with initial remission, three patients had a late recurrence (25% of patients with initial remission). These patients were disease-free for 98, 123, and 163 months, respectively, following their initial transsphenoidal resection.
Two patients with GH-secreting tumors received radiotherapy postoperatively and were disease-free at follow-up review 76 and 164 months later. The third patient had a subtotal resection and was followed with stable disease for 53 months, when tumor growth was observed prompting pituitary irradiation. She had a good response and exhibited no evidence of disease on imaging studies at follow-up review 5 months after completion of radiotherapy.
One patient with a clinically nonfunctioning adenoma received radiotherapy postoperatively and had no clinical evidence of disease at the 150-month follow-up review. The other patient with a nonsecreting tumor was not irradiated and had no evidence of disease at 19 months.
Discussion
Epidemiological Data
Pituitary adenomas are uncommon in childhood, becoming increasingly more frequent during the adolescent years; therefore, incidence data are scarce. In an epidemiological review of pituitary adenomas, Gold j~ estimated that the average annual incidence was 0.1 per million children, constituting 1.1% of all intracranial tumors of childhood. Hoffman ~4 reported an incidence of 1.2% of all supratentorial tumors treated during a 25-year period at The Hospital for Sick Children. In our series, children represented 2.3% of all individuals with pituitary adenomas treated by transsphenoidal surgery. This figure is comparable with the incidence of 2.6% reported in their series by Haddad, et at., 13 but considerably lower than the 10% of pediatric cases described by Richmond and Wilson. 37 However, in the latter series the 25 pediatric patients (identified from a group of 250 patients treated for pituitary adenoma) were included as pediatric patients if they had an onset of symptoms before the age of 20 years. On review of the series, it appears that there were nine patients who were operated on before their 17th birthday (the inclusion criterion for our series), or 3.6% of all transsphenoidally operated pituitary tumor patients. This same incidence was reported by Ludecke, et aL, ~5 who used surgery by 18 years of age as their inclusion criterion.
Patient Characteristics
The distribution of patients by diagnostic group was similar to that seen in other large series of pediatric pituitary adenomas, with ACTH-and PRL-secreting tumors being the most common and a relative lack of nonfunctioning adenomas.t2. 13,25.37 This is the opposite finding to that seen in adults, where nonfunetioning tumors predominate? 8 In addition, there were no TSH-or LH~TSH-secreting tumors in our series. The development of TSH hypersecretion is thought to be secondary to long-standing end-organ failure (primary hypothyroidism) and therefore is not likely to be seen in childrenr 8 For the same reason, the presence of elevated levels of circulating LH or FSH is unusual in a child and is more likely to indicate the presence of an alpha-subunit-secreting tumor, which can be assayed directly. 36 The sex distribution observed in our series largely reflected the relative contributions of the two major diagnostic groups, that is, the patients with PRL-and ACTH-secreting tumors. A number of other reports have also established that prolactinomas occur predominantly in females, ~z,~3,a3,42 although certainly a number of males were also present in each series and have been reported in several single case reports? ,< 8,38,4,,43,50 A preponderance of males among patients with Cushing's disease was also observed by Grigsby, et al. ~-" Shalet 4e found that there was equal sex distribution in childhood Cushing's disease, as compared with the female preponderance among adult patients, while Haddad, et al.] ~ had only one male patient in their series of five patients with Cushing's disease. In an earlier series reported by Laws, el al., 23 there was also an excess of female patients. It is our theory that the differences cited reflect the inclusion of older patients in these series, which results in a more "adulttype" composition of the patient population than was observed in our series.
The majority of our patients underwent operation during their adolescent years, and for the most part had been symptomatic for only a short time. The exception to this was among the patients with ACTH-secreting tumors, where there was a number of younger patients. These included a 7-year-old boy with Nelson-Salassa syndrome, who was the youngest surgical patient in the series and who had also suffered the onset of symptoms in infancy. It was believed that the longer median duration of symptoms among the patients with ACTH secretion was in part due to the insidious nature of the disease and the difficulties involved in making the diagnosis. The latter was certainly the case in one of the two patients with Nelson-Salassa syndrome. The development of symptomatic Cushing's disease in infancy has previously been described. 2~
As in our series, there are no reports in the literature of prolactinomas in infancy, although there is one report of the diagnosis being made in a 4-year-old boy? Similarly, a GH-secreting tumor in an infant has been reported only once] and there was none in our series.
Clinical Presentation
Presenting symptoms and signs in these patients generally reflect early endocrinopathy rather than mass effect. In part, this is secondary to the relative lack of nonfunctioning tumors, as noted above. However, in the pediatric age group, as opposed to in adults, pituitary dysfunction is likely to be noticed by patients and their families sooner because of disturbances in the ongoing process of puberty and linear growth? ,~3,26,33' 37,42 This is particularly true in cases of precocious puberty, 8.43 galactorrhea in males, 5~ and gigantism. 2,15,4<5] It is of interest to note that gigantism/ acromegaly in the absence of elevated GH was observed in one of our PRL-hypersecreting patients. This has been termed "fugitive acromegaly" and is seen in patients with plurihormonal tumors (see below)? <4" Neurological symptoms and signs were limited to visual field defects, and these were found only in patients with tumor extension beyond the sella. These tended to improve with treatment, as has been noted in other seriesJ 2 14,23.37
Laboratory and Radiological Data
The preoperative biochemical evaluation of the patients in this series did not differ significantly from that in other pediatric series or representative adult series. 3"4"7' 9' 13' 27"2~' 37"39' 42' 49 Although the imaging modality employed varied over the time period of the study, there is no obvious trend that appears to be unique to the pediatric age group. As with adult series, smaller tumors are best identified on MR imaging, and not until significant tumor extension exists beyond the confines of the sella are there significant changes on angiography and skull radiography. While not an adequate technique for screening or diagnostic purposes, skull radiography was routinely obtained in the patients in this series for preoperative assessment of the sphenoid sinus and selIar floor. 2j
Surgical Techniques and Complications
The surgical techniques used in this series did not differ significantly from standard techniques undertaken in adults in terms of the overall approach and tumor resection21, 48 The most commonly cited alteration in technique in pediatric patients is the need to drill out the sphenoid sinus in those patients with the "conchal" or prepneumatized type of sinus, 3~ as noted by other authors. 7,25,26 In these series, the patients with conchal sinuses were usually being treated for ACTHsecreting tumors, although it is unclear whether this anatomical feature is somehow related to this particular disease or whether it is simply a feature of younger patients.
The results of this series confirm that transsphenoidal approaches to the pituitary gland are safe and effective in this age group. There is no apparent morbidity specific to this age group, particularly with regard to the further development of facial structures, that has been identified in this or any other series of pediatric pituitary adenomas. 7,132325,26,37 It is recognized that the majority of patients in these reports are adolescents and have already reached their adult facial configuration prior to transsphenoidal surgery, but in our series and in the others cited, there are several younger patients who have undergone a transsphenoidal surgical approach without apparent effect on facial development. The youngest patient cited in the literature is a 4-year-old boy in the series reported by Ludecke, et aL zs
Pathological Data
Based on the results of this series, there is no clear evidence that pituitary adenomas in this age group are more likely to be locally invasive or "aggressive," as had been suggested earlier? s,19,33 In reviewing these series, two of which were small, it is our opinion that the outcome was biased by the inclusion of patients from the era before modern transaxial imaging techniques; the result was that a number of these tumors had attained significant size, with extension beyond the seila, before the diagnosis was made. This was also the conclusion of Richmond and Wilson. 37 Certainly, the most striking feature of the pathological studies performed on the tumors in this group is the presence of a large proportion of plurihormonal tumors. This finding correlates with that of Scheithauer, et al., ~ who reviewed a series of plurihormonal pituitary adenomas and found that 10% of them were resected in childhood or adolescence, which is clearly a far higher proportion of pediatric cases than in the overall population of pituitary adenoma patients. They also noted that 50% of all GH-secreting adenomas were plurihormonal and that 80% were macroadenomas. This finding is also supported by our results.
Outcome
The improvement of visual field defects after tumor resection (and the maintenance of a normal neurological examination) was typical of other series with transsphenoidally operated patients. 3,~,~~ The majority of patients in our series did not require pituitary supplementation, and full hormonal replacement therapy was necessary in less than 9% of cases. This was also the case in a number of other series and it has been suggested that the need for postoperative supplementation is usually a function of the preoperative degree of pituitary insufficiency. 7,13,23,~5,37 The retention of good pituitary function would also predict the resumption of menstrual cycles and the potential for future pregnancy; Laws, et aL, 22 found that 84% of women desiring pregnancy following surgery for PRL-seereting adenomas were successful.
Overall, the results of this series in terms of tumor control were similar to those reported in the literature. The outcome of patients with PRL-secreting adenomas appears to be a function of tumor size, with microadenomas exhibiting a high cure rate following resection alone and macroadenomas requiring adjuvant radiotherapy and/or bromocriptine, but with good response. 17,22,3~ It is rare that a patient with a PRLsecreting tumor remains unresponsive to all three therapeutic modalities. 5 Patients with ACTH-secreting tumors were often cured if they went into initial remission, as was seen in other pediatric and adult series. 3,2729,32,46 Although the recurrence rate among patients with initial remission was high (25%), we note that the tumor regrowth occurred at very long intervals (8 to 13 years) following resection. In a series of patients with long-term follow-up review, Nakane, et aL, 32 noted that recurrences were found after 19 to 82 months of remission. They postulated that this was due to regrowth of adenoma cells remaining in the gland after the initial resection. It is certainly possible that the late recurrences in our series were caused in this fashion, but we also venture to suggest that in the setting of a long period of remission the recurrence may be due to induction of a new adenoma by the same mechanism that gave rise to the first tumor, and that perhaps this phenomenon has not been observed in adults due to the shorter follow-up period and patient longevity. Our experience with GH-secreting and nonfunctioning tumors in this series is too small for objective comment, although other reports on GHsecreting tumors suggest a frequent need for multimodality therapyY
Conclusions
Pituitary adenomas in the pediatric age group can become symptomatic in childhood (particularly ACTH-secreting tumors), but the majority present in adolescence. Adrenocorticolropic hormone-and PRLsecreting tumors predominate and have trcatment outcomes similar to those reported for larger adult series. The pathology of these adenomas demonstrates a high proportion of plurihormonal lesions, which are frequently macroadenomas. The transsphenoidal technique is similar to that used in adults and is safe and effective in the management of these uncommon lesions.
